(Q57655312)

Stefan Borgwardt

5

0 references

Ludwig Kappos

7

Ludwig Kappos

0 references

Frederik Barkhof

11

Frederik Barkhof

0 references

Stephen L. Hauser

9

Stephen L Hauser

0 references

Kerstin Bendfeldt

2

Kerstin Bendfeldt

0 references

author name string

Stefan D Roosendaal

1

0 references

Hugo Vrenken

3

0 references

Chris H Polman

4

0 references

Ernst W Radue

6

0 references

Daniel Pelletier

8

0 references

Jeroen JG Geurts

Multiple Sclerosis Journal

12

0 references

publication date

17 May 2011

0 references

published in

0 references

volume

17

0 references

issue

9

0 references

page(s)

1098-1106

0 references

cites work

Subpial demyelination in the cerebral cortex of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Connecting white matter injury and thalamic atrophy in clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Gray matter atrophy in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Cortical atrophy is relevant in multiple sclerosis at clinical onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Relating neocortical pathology to disability progression in multiple sclerosis using MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Focal thinning of the cerebral cortex in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis — A longitudinal voxel-based morphometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511404916